Detalles de la búsqueda
1.
Phase II trial of nab-paclitaxel compared with docetaxel as first-line chemotherapy in patients with metastatic breast cancer: final analysis of overall survival.
Clin Breast Cancer
; 12(5): 313-21, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22728026
2.
First-line treatment of advanced breast cancer with sunitinib in combination with docetaxel versus docetaxel alone: results of a prospective, randomized phase III study.
J Clin Oncol
; 30(9): 921-9, 2012 Mar 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-22331954
3.
A dose finding study of weekly and every-3-week nab-Paclitaxel followed by carboplatin as first-line therapy in patients with advanced non-small cell lung cancer.
J Thorac Oncol
; 5(6): 852-61, 2010 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20521351
4.
Trabectedin plus pegylated liposomal Doxorubicin in recurrent ovarian cancer.
J Clin Oncol
; 28(19): 3107-14, 2010 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20516432
5.
Significantly longer progression-free survival with nab-paclitaxel compared with docetaxel as first-line therapy for metastatic breast cancer.
J Clin Oncol
; 27(22): 3611-9, 2009 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19470941
6.
Pegylated liposomal doxorubicin plus docetaxel significantly improves time to progression without additive cardiotoxicity compared with docetaxel monotherapy in patients with advanced breast cancer previously treated with neoadjuvant-adjuvant anthracycline therapy: results from a randomized phase III study.
J Clin Oncol
; 27(27): 4522-9, 2009 Sep 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-19687336
Resultados
1 -
6
de 6
1
Próxima >
>>